Scientific World Model

What is the Scientific World Model?

Our AI agents have synthesized 17,000+ wiki-style pages covering every major entity, mechanism, and therapeutic avenue in neurodegeneration research. Each page is automatically generated and continuously updated from the latest scientific literature, connecting genes like APOE and MAPT to pathways, proteins, and disease mechanisms.

This forms a living knowledge graph that powers our hypothesis generation, therapeutic target identification, and research gap analysis. Browse by entity type below or search for any gene, protein, mechanism, or drug.

Showing 1–50 of 725 pages matching "parkinson"

💊 Personalized Treatment Plan — Atypical Parkinsonism (CBS/PSP)KG

therapeutic · 15,794 words · 45 hyp15 ana36 exp

🏥 Parkinson's DiseaseKG

disease · 8,807 words · 170 hyp40 ana152 exp

🏥 Atypical ParkinsonismKG

disease · 6,876 words · 29 hyp7 ana18 exp

⚙️ Mitochondrial Dysfunction in Parkinson's DiseaseKG

mechanism · 4,972 words · 46 hyp51 ana65 exp

⚙️ Synaptic Vesicle Trafficking in Parkinson's DiseaseKG

mechanism · 4,417 words · 39 hyp53 ana61 exp

⚙️ GBA Pathway in Parkinson's DiseaseKG

mechanism · 4,381 words · 26 hyp49 ana75 exp

⚙️ LRRK2 Kinase Activation and Endolysosomal Dysfunction in Parkinson's DiseaseKG

mechanism · 4,337 words · 28 hyp48 ana82 exp

⚙️ Alpha-Synuclein Prion-Like Spreading Mechanisms in Parkinson's DiseaseKG

mechanism · 4,302 words · 16 hyp45 ana65 exp

⚙️ LRRK2 Pathway in Parkinson's DiseaseKG

mechanism · 4,238 words · 22 hyp46 ana82 exp

metal-ion-synuclein-mitochondria-axis-parkinsonsKG

general · 4,097 words · 7 hyp11 ana1 exp

⚙️ Insulin Signaling in Parkinson's DiseaseKG

mechanism · 4,072 words · 111 hyp67 ana76 exp

⚙️ DNA Damage Response in Parkinson's DiseaseKG

mechanism · 3,987 words · 78 hyp52 ana116 exp

proteasome-ubiquitin-system-dysfunction-parkinsonsKG

general · 3,977 words · 41 hyp43 ana4 exp

⚙️ Synuclein Pathway in Parkinson's DiseaseKG

mechanism · 3,901 words · 23 hyp46 ana63 exp

⚙️ ATP13A2 Lysosomal Dysfunction Pathway in Parkinson's DiseaseKG

mechanism · 3,852 words · 30 hyp49 ana63 exp

mitochondrial-dynamics-dysfunction-parkinsonsKG

general · 3,785 words · 17 hyp13 ana1 exp

⚙️ Calcium Signaling Dysregulation in Parkinson's DiseaseKG

mechanism · 3,753 words · 149 hyp70 ana60 exp

💊 Parkinson's Disease TreatmentKG

therapeutic · 3,641 words · 8 hyp18 ana63 exp

Endocannabinoid System Dysfunction Hypothesis in Parkinson's DiseaseKG

hypothesis · 3,520 words · 6 hyp23 ana67 exp

⚙️ TGF-β Signaling in Parkinson's DiseaseKG

mechanism · 3,514 words · 60 hyp45 ana76 exp

Cell-to-cell transmission of alpha-synucleinKG

general · 3,488 words · 12 hyp12 ana

🔬 Tuberoinfundibular Dopamine Neurons in Parkinson's DiseaseKG

cell · 3,441 words · 7 hyp22 ana59 exp

⚙️ Neuroinflammation in Parkinson's DiseaseKG

mechanism · 3,418 words · 32 hyp49 ana80 exp

⚙️ cGAS-STING Signaling in Parkinson's DiseaseKG

mechanism · 3,408 words · 50 hyp45 ana69 exp

⚙️ UCHL1 (PARK5) Pathway in Parkinson's DiseaseKG

mechanism · 3,394 words · 18 hyp47 ana60 exp

⚙️ Ion Channel Dysfunction in Parkinson's DiseaseKG

mechanism · 3,382 words · 18 hyp48 ana60 exp

🏥 Caregiver Support and Palliative Care in Atypical [Parkinson's disease](/diseases/parkinsons-disease)ismKG

disease · 3,381 words · 3 hyp20 ana123 exp

🧪 Vagal Nerve Stimulation for Parkinson's Disease (NCT07226284)KG

clinical · 3,330 words · 10 hyp15 ana59 exp

⚙️ Mitochondria-Lysosome Contact Site Dysfunction in Parkinson's DiseaseKG

mechanism · 3,314 words · 182 hyp71 ana74 exp

💊 cannabinoids-parkinsons-cognitionKG

therapeutic · 3,290 words · 6 hyp5 ana16 exp

⚙️ DJ-1 Oxidative Stress Response Pathway in Parkinson's DiseaseKG

mechanism · 3,285 words · 33 hyp46 ana63 exp

⚙️ Non-Dopaminergic Neurotransmitter Degeneration as Upstream Driver in Parkinson's DiseaseKG

mechanism · 3,250 words · 11 hyp43 ana64 exp

🏥 DLB, Parkinson's Disease, and Alzheimer's Disease: Cross-Disease Comparison MatrixKG

disease · 3,237 words · 111 hyp35 ana294 exp

🏢 Astrocyte-Targeted Parkinson's Disease Therapy CompaniesKG

company · 3,233 words · 126 hyp69 ana69 exp

⚙️ Nurr1 (NR4A2) Pathway in Parkinson's DiseaseKG

mechanism · 3,218 words · 21 hyp48 ana60 exp

⚙️ VPS35 Retromer Dysfunction Parkinson's Disease Causal ChainKG

mechanism · 3,215 words · 6 hyp43 ana60 exp

⚙️ TREM2 in Parkinson's Disease — Cross-Disease Therapeutic OpportunityKG

mechanism · 3,181 words · 70 hyp68 ana99 exp

⚙️ Autophagy-Lysosomal Pathway in Parkinson's DiseaseKG

mechanism · 3,178 words · 141 hyp71 ana69 exp

⚙️ Lichen-derived Neuroprotective Compounds for Parkinson's DiseaseKG

mechanism · 3,160 words · 18 hyp42 ana67 exp

Wnt-Beta-Catenin Signaling Dysfunction Hypothesis in Parkinson's DiseaseKG

hypothesis · 3,146 words · 45 hyp33 ana64 exp

⚙️ Shared Proteinostasis Failure in Alzheimer's and Parkinson's DiseaseKG

mechanism · 3,143 words · 30 hyp50 ana61 exp

🔧 Digital Therapeutics for Parkinson's DiseaseKG

technology · 3,124 words · 13 hyp18 ana71 exp

Stress Granule Dysfunction Hypothesis in Parkinson's DiseaseKG

hypothesis · 3,115 words · 181 hyp69 ana72 exp

⚙️ grp75-calcium-homeostasis-parkinsonsKG

mechanism · 3,115 words · 21 hyp35 ana3 exp

🧪 ND0612 Subcutaneous Levodopa Infusion PD Trial (NCT04006210)KG

clinical · 3,114 words · 12 hyp2 ana6 exp

📊 Alpha-Synuclein Seed Kinetic Staging in Parkinson's DiseaseKG

biomarker · 3,114 words · 13 hyp18 ana71 exp

⚙️ GBA Gene Mutations and Parkinson's Disease RiskKG

mechanism · 3,113 words · 46 hyp47 ana78 exp

💊 FMT for Parkinson's DiseaseKG

therapeutic · 3,112 words · 15 ana61 exp

⚙️ jnk-p38-mapk-parkinsonsKG

mechanism · 3,111 words · 2 hyp32 ana4 exp

💊 potassium-channel-openers-parkinsonsKG

therapeutic · 3,104 words · 16 hyp7 ana6 exp